Collegium Pharmaceutical (COLL) PT Raised to $36 at Piper Sandler
Tweet
Share
E-mailGet Alerts COLL Hot Sheet
Price: $28.23 +0.28%
Rating Summary:
7 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
7 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Piper Sandler analyst David Amsellem raised the price target on Collegium Pharmaceutical (NASDAQ: COLL) to $36.00 (from $35.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Collegium Pharma (COLL) 2700 contracts of August 39 calls trade
- Solar Industries (SOIL:IN) PT Raised to INR23,500 at ICICI Securities
- Fiserv (FISV) PT Lowered to $60 at Freedom Broker
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
